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Abstract
Background: Psoas contracture is known to cause abnormal hip motion in patients with cerebral palsy. The
authors investigated the clinical relevance of hip kinematic and kinetic parameters, and 3D modeled psoas length
in terms of discriminant validty, convergent validity, and responsiveness.
Methods: Twenty-four patients with cerebral palsy (mean age 6.9 years) and 28 normal children (mean age 7.6
years) were included. Kinematic and kinetic data were obtained by three dimensional gait analysis, and psoas
lengths were determined using a musculoskeletal modeling technique. Validity of the hip parameters were
evaluated.
Results: In discriminant validity, maximum psoas length (effect size r = 0.740), maximum pelvic tilt (0.710),
maximum hip flexion in late swing (0.728), maximum hip extension in stance (0.743), and hip flexor index (0.792)
showed favorable discriminant ability between the normal controls and the patients. In convergent validity,
maximum psoas length was not significantly correlated with maximum hip extension in stance in control group
whereas it was correlated with maximum hip extension in stance (r = -0.933, p < 0.001) in the patients group. In
responsiveness, maximum pelvic tilt (p = 0.008), maximum hip extension in stance (p = 0.001), maximum psoas
length (p < 0.001), and hip flexor index (p < 0.001) showed significant improvement post-operatively.
Conclusions: Maximum pelvic tilt, maximum psoas length, hip flexor index, and maximum hip extension in stance
were found to be clinically relevant parameters in evaluating hip flexor contracture.
Background
Hip flexion deformity or spasticity is a cause of the
abnormal gait observed in cerebral palsy patients. Hip
flexor spasticity was reported to cause dynamic restric-
tion of hip extension in the terminal stance and become
fixed hip flexion contracture with age in those patients
[1-3]. The psoas muscle is a primary cause of hip flexion
contracture [4,5] and has been known to be associated
with increased anterior pelvic tilt, crouch gait, hip
instability and lumbar lordosis, which can eventually
cause spondylosis and back pain [1,4,6-8]. The psoas
muscle plays an important role in advancing the lower
leg during normal gait [4], whereas the dysphasic activ-
ity of the hip flexor muscle opposes and limits hip
extension in patients with cerebral palsy [4,9-11], which
reduces the stride length and gait efficacy.
Despite the role of this muscle in the pathologic gait,
the surgical indications of psoas lengthening are some-
what vague. Furthermore, although several kinematic and
kinetic variables were shown to represent hip motion
during gait and those variables were used to report
changes after single event multilevel surgery in patients
with cerebral palsy, the clinical relevance of those vari-
ables measuring the hip flexor function is unclear.
After 3D modeled muscle length calculated from kine-
matic data of gait analysis was devised, it was believed
that this could be especially useful in measuring
dynamic length of multijoint muscle during gait because
reflecting the multijoint movement is not easy to follow
[12]. Several studies have investigated 3D modeled psoas
length [13-15], but its clinical relevance has not been
sufficiently verified.
The kinematic and kinetic data of hip motion as well
as the 3D psoas length need to be evaluated accurately
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kinematic and kinetic variables measuring the hip flexor
function and the 3D modeled psoas length by 1) discri-
minating the pathologic gait from the normal gait (dis-
criminant validity), 2) correlating those variables
(convergent validity), and 3) analyzing post-operative
changes (responsiveness).
Methods
Inclusion/Exclusion Criteria
This retrospective study was performed at a tertiary
referral center for cerebral palsy and was approved by
the institutional review board. The study was designed
to include a group of normal children and a group of
patients with cerebral palsy. For the group of normal
children, volunteers aged from 5 to 15 years old were
recruited. The exclusion criteria were known neuromus-
cular disease and an abnormality of lower limb align-
ment. For the study group, patient selection was based
on the medical records since 1997. In order to have a
homogenous group of the patients with cerebral palsy,
the following inclusion criteria were used: 1) ambulatory
patients with spastic diplegia (GMFCS level I-II, gross
motor function classification system [16], who had the
representative gait pattern consisting of a jump gait pat-
tern [17] with intoeing, equinus, stiff knee, and femoral
antetorsion, which is one of the most representative gait
patterns of diplega; 2) patients who underwent bilateral
single event multilevel surgery (bilateral tendo-Achilles
lengthening, distal hamstring lengthening, rectus femoris
transfer, femoral derotational osteotomy); 3) a follow-up
period of more than one year; 4) the pre-operative and
post-operative gait analysis; and 5) 5-15 years of age.
The exclusion criteria were patients with a history of
gait corrective surgery or selective dorsal rhizotomy,
neuromuscular diseases other than cerebral palsy, an
asymmetrical gait pattern and surgical procedures other
than the index procedures. The demographic data, phy-
sical examination (including Thomas test [18]), and gait
parameters of the patients, including gender, age,
GMFCS level, cadence, step length, and walking speed,
were collected. Informed consent for the retrospective
review of the gait analysis data of patients and control
group was waived by the institutional review board at
our hospital.
Kinematic and kinetic data
The gait analysis laboratory was equipped with a Vicon
370 (Oxford Metrix, Oxford, U K )s y s t e mc o n s i s t i n go f
seven CCD cameras and two force plates. Motion was
captured while the subjects walked barefoot on a nine-
meter walkway, and the kinematic and kinetic data were
obtained, which were averaged by three trials. The hip
flexion and extension, hip rotation, and pelvic tilt were
the key kinematic variables. The kinetic data including
time of crossover in the hip flexion-extension moment
and the power burst of hip flexor in the late stance were
obtained. The hip flexor index was calculated from the
kinematic and kinetic data of the hip and pelvic motion,
which were maximum pelvic tilt, pelvic tilt range, maxi-
mum hip extension in stance, and late stance power
burst of hip joint (H3) [19].
3D modeled psoas length
The psoas length was obtained using interactive muscu-
loskeletal modeling [20] software (SIMM, Motion Analy-
sis Corporation, Santa Rosa, CA) (Figures 1 and 2). The
psoas length was determined to be between the muscu-
lar origin and insertion, which were the transverse pro-
cess of the lumbar spine and lesser trochanter of the
femur, respectively. However, in this study, spine motion
was not included. Calculated average psoas origin was
used, and calculated average pelvic brim was used as via
Figure 1 Three dimensional musculoskeletal modeling image
depicting the psoas muscles between their bony origins and
insertions with the knee and hip joint in 0° of extension, which
represents static psoas length.
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kinematic data of femur and pelvis. Although psoas is a
multijoint muscle, only hip angles were reflected in its
length. The psoas length was standardized by dividing
the calculated psoas length during gait by the muscle
length when the subjects were in a simulated anatomic
position. This standardized psoas length was recorded
continuously during the gait cycle (Figure 3) and
included for analysis.
Validity of kinematic and kinetic variables, and psoas
length in hip flexor function
There are no gold standards for measuring hip flexor
function during gait. Therefore, the validity of kinematic
and kinetic data regarding hip flexor function relies on
the content validity and construct validity. Construct
validity is comprised of the discriminant validity and
convergent validity. The discriminant validity [21] is one
facet of the construct validity, and reflects the degree to
which an instrument can distinguish between or among
different concepts or constructs [22]. This is the ability
to detect clinically relevant difference. In this study,
effect-size r [23] between the normal control and the
patient groups were assessed as in previous studies
[24-27]. Convergent validity [21,28] which is another
type of construct validity, occurs when the scales of a
measurement correlate as expected with the related
scales of another measurement. In this study, the 3D
modeled psoas lengths were compared with the kine-
matic and kinetic hip parameters representing hip and
pelvic motion. Responsiveness [29] was tested by com-
paring the pre-operative and post-operative variables.
Statistical Analysis
One of the principal variables in this study was the
psoas length on which we had few previous studies that
we could refer to. We assumed that 1% of difference in
psoas length between the control and patient groups
would be clinically relevant, and prior power analysis
(alpha error 0.05, power 0.8) revealed that over 17 sub-
jects would be needed on each group. The average of
the variables of right and left legs were used for data
analysis to ensure data independence.
Statistical analysis was performed using SPSS Ver. 15.0
(SPSS, Chicago, Illinois). The normal distribution of the
data was tested using a Kolmogorov-Smirnov test. The
discriminant validity was assessed by the effect-size r
[23] for the kinematic and kinetic variables and psoas
length. The Effect size is a name given to a family of
indices that measures the magnitude of a certain effect
and is generally measured in two ways: as the standar-
dized difference between two means, or as the correla-
tion between the independent variable classification
and individual scores on the dependent variable.
Figure 2 Psoas length (distance between its bony origin and
insertion) changed throughout the gait cycle, which is
dynamic psoas length.
Figure 3 Standardized psoas length was calculated and
depicted throughout the gait cycle, which is dynamic psoas
length divided by static psoas length.
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(effect-size r) and was used for the discriminant validity
in this study. Correlations between each of the kine-
matic and kinetic variables and psoas length were ana-
lyzed using a Pearson’s correlation test for convergent
validity. The comparison of the data between the
patients and normal controls was performed using a
t-test, and the post-operative changes in the patients
were analyzed using a paired t-test. A p value < 0.05
was considered significant. For multiple testing, statisti-
cal significance was adjusted for family wise error.
Results
Twenty-four patients with cerebral palsy were finally
included in this study. The mean age of the patients was
6.9 years (SD 1.6 years), and there were 15 males and
9 females. The GMFCS levels were I in 15 patients and
II in 9 patients. The mean age of the 28 normal controls
was 7.6 years (SD 2.4 years), and there were 17 males
and 11 females. The mean age and gender ratio were
not significantly different between the two groups (p =
0.222 and p = 0.973) (Table 1).
Discriminant validity of kinematic and kinetic data, and
psoas length
The discriminant validity between the patients and nor-
mal control group was highest in hip flexor index (effect
size r = 0.792) followed by maximum hip extension in
stance (0.743), maximum psoas length (0.740), maxi-
mum hip flexion in late swing (0.728) and maximum
pelvic tilt (0.710). Kinetic data, including the time of
crossover in hip flexion-extension moment (0.059) and
power burst of hip flexor in late stance (0.020), showed
an unsatisfactory discriminant validity (Table 2).
Convergent validity of kinematic and kinetic data, and
psoas length
In the normal control group, the correlation coefficient
between the maximum psoas length and maximum
hip extension in stance was -0.420 (p = 0.065). The
maximum psoas length showed correlation coefficients
of 0.601, -0.651, and -0.448 with the step length, time of
crossover in hip flexion-extension moment, and hip
flexor index, respectively. The minimum psoas length
showed no significant correlation with the kinematic
and kinetic variables (Table 3).
In the patients group, the maximum psoas length
showed a significant correlation with the maximum hip
extension in stance (r = -0.933, p < 0.001). The correla-
tion coefficient between the maximum psoas length and
hip flexor index was -0.467 (p = 0.001). There was no
significant correlation between the maximum psoas
length and step length (Table 4). Thomas test did not
show significant correlation with maximum psoas length
in control and patient groups.
Responsiveness of kinematic and kinetic data,
and psoas length
The maximum pelvic tilt, maximum hip extension in
stance, maximum psoas length and hip flexor index
showed significant improvement after surgery (p =
0.008, p = 0.001, p < 0.001, and p < 0.001 respec-
tively). There was no significant post-operative change
in the range of psoas lengths (p = 0.158) and power
Table 1 Demographic data and gait parameters
Patients Normal controls p
N2 4 2 8
Age (years) 6.9 (1.6) 7.6 (2.4) 0.222
Sex (M:F) 15:9 17:11 0.973
Follow up period (years) 1.1 (0.2) -
GMFCS level (I/II) 15/9 -
Gait parameters
Cadence (No./min) 101.2 (14.2) 112.5 (12.9) 0.001
Step length (cm) 35.3 (6.2) 53.0 (9.2) <0.001
Walking speed (cm/s) 59.9 (13.5) 99.9 (16.9) <0.001
Data are presented as mean (SD).
Table 2 Discriminant validity of hip parameters
Cerebral
palsy
Normal
controls
p Effect
size (r)
Thomas test (°) 7.4 (6.8) 0.6 (1.9) <0.001 0.561
Pelvic tilt (°)
maximum 21.9 (4.9) 12.1 (4.8) <0.001 0.710
minimum 12.6 (5.9) 6.9 (3.9) 0.008 0.497
range 9.4 (3.5) 5.2 (2.5) 0.002 0.562
mean 17.5 (5.1) 9.5 (4.1) <0.001 0.654
Max hip extension in
stance (°)
-0.5 (6.1) 11.1 (4.2) <0.001 0.743
Max hip flexion in late
swing (°)
50.4 (5.9) 38.2 (5.5) <0.001 0.728
Hip rotation (°)
maximum 12.8 (8.2) 12.8 (9.9) 0.997 0.005
minimum 0.2 (9.2) -11.8 (13.2) 0.005 0.467
range 12.6 (4.1) 24.7 (11.5) 0.009 0.573
mean 6.3 (8.9) 0.1 (10.0) 0.086 0.308
Psoas length (%)
maximum 99.2 (1.3) 101.5 (0.8) <0.001 0.740
minimum 87.5 (1.4) 90.4 (1.7) <0.001 0.684
range 11.7 (1.5) 11.1 (1.2) 0.126 0.212
mean 93.6 (1.3) 96.0 (1.3) <0.001 0.676
TOC (%) 28.2 (11.5) 27.0 (8.6) 0.767 0.059
H3 (W/kg) 0.3 (0.4) 0.3 (0.4) 0.920 0.020
HFI 5.9 (1.4) 1.9 (1.7) <0.001 0.792
TOC, time of cross over in hip flexion/extension moment; H3, late swing
power burst in hip joint flexion/extension power; HFI, hip flexor index.
Data are presented as mean (SD).
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(Table 5).
Discussion
The patients with cerebral palsy showed a shorter psoas
length and smaller maximum hip extension in stance
than the normal control group. The maximum psoas
length was found to reflect the kinetic and kinematic
data of hip motion. The hip flexor index showed satis-
factory discriminant and convergent validity, showing a
significant correlation with the psoas length. The result
of the cross correlation revealed an excellent correlation
between the maximum psoas length and maximum hip
extension in the patients group (Table 6).
The patients with cerebral palsy showed a shorter
maximum psoas length, larger pelvic tilt, and more
sagittal pelvic motion than the normal control group.
The maximum hip extension in stance was limited in
the patient group, which was possibly caused by a
Table 3 Correlation coefficients between psoas length
and gait parameters in control group
Max PL Min PL Range PL Mean PL
Thomas test (°) -0.253 -0.416* 0.407* -0.450*
Pelvic tilt (°)
maximum -0.576* -0.206 0.050 -0.399
minimum -0.595* -0.141 -0.018 -0.296
range -0.110 -0.140 0.108 -0.240
mean -0.672* -0.226 0.044 -0.420
Max hip extension in
stance (°)
-0.420 -0.029 -0.082 -0.201
Max hip flexion in late
swing (°)
-0.312 -0.327 0.238 -0.302
Hip rotation (°)
maximum 0.140 -0.098 0.133 -0.172
minimum -0.316 -0.101 0.015 -0.233
range 0.532* 0.012 0.128 0.088
mean -0.128 -0.091 0.055 -0.226
TOC (%) -0.651* -0.085 -0.107 -0.344
H3 (W/kg) 0.140 -0.305 0.326 -0.234
HFI -0.448* -0.081 -0.039 -0.269
Cadence (No./min) -0.278 -0.208 0.131 -0.288
Step length (cm) 0.601* 0.206 -0.044 0.355
Walking speed (cm/s) 0.511* 0.149 -0.011 0.232
TOC, time of cross over in hip flexion/extension moment; H3, late swing power
burst in hip joint flexion/extension power; HFI, hip flexor index; *, p < 0.05.
Table 4 Correlation coefficients between psoas length
and gait parameters in patients group
Max PL Min PL Range PL Mean PL
Thomas test (°) -0.116 0.408* -0.476* 0.200
Pelvic tilt (°)
maximum -0.331* -0.611* 0.326* -0.610*
minimum -0.446* -0.474* 0.109 -0.547*
range 0.286* -0.054 0.268 0.069
mean -0.457* -0.560* 0.182 -0.635*
Max hip extension in
stance (°)
-0.933* -0.299* -0.427* -0.747*
Max hip flexion in late
swing (°)
-0.137 -0.740* 0.596* -0.585*
Hip rotation (°)
maximum -0.367* -0.445* 0.142 -0.495*
minimum -0.388* -0.423* 0.105 -0.442*
range 0.098 -0.003 0.077 -0.072
mean -0.369* -0.421* 0.117 -0.450*
TOC (%) -0.324* -0.183 -0.090 -0.417*
H3 (W/kg) 0.135 0.004 0.106 0.009
HFI -0.467* -0.503* 0.120 -0.646*
Cadence (No./min) -0.133 -0.001 -0.100 -0.109
Step length (cm) 0.101 -0.074 0.147 -0.122
Walking speed (cm/s) 0.040 -0.022 0.051 -0.122
TOC, time of cross over in hip flexion/extension moment; H3, late swing power
burst in hip joint flexion/extension power; HFI, hip flexor index; *, p < 0.05.
Table 5 Responsiveness of psoas length and gait
parameters in patients with spastic diplegia
Pre-operative Post-operative p
Pelvic tilt (°)
maximum 21.9 (4.9) 18.8 (4.9) 0.008
minimum 12.6 (5.9) 12.9 (5.0) 0.897
range 9.4 (3.5) 5.9 (2.1) <0.001
mean 17.5 (5.1) 15.9 (4.9) 0.126
Max hip extension in
stance (°)
-0.5 (6.1) 4.6 (7.5) 0.001
Max hip flexion in late
swing (°)
50.4 (5.9) 42.9 (5.1) <0.001
Hip rotation (°)
maximum 12.8 (8.2) 10.0 (4.9) 0.107
minimum 0.2 (9.2) -5.2 (7.0) 0.016
range 12.6 (4.1) 15.3 (4.6) 0.015
mean 6.3 (8.9) 2.3 (5.8) 0.051
Psoas length (%)
maximum 99.2 (1.3) 100.3 (1.2) <0.001
minimum 87.5 (1.4) 89.3 (1.6) <0.001
range 11.7 (1.5) 11.1 (1.9) 0.158
mean 93.6 (1.3) 95.0 (1.2) <0.001
TOC (%) 28.2 (11.5) 24.6 (12.3) 0.173
H3 (W/kg) 0.3 (0.4) 0.5 (2.0) 0.627
HFI 5.9 (1.4) 3.8 (2.0) <0.001
Cadence (No./min) 101.2 (14.2) 103.0 (16.6) 0.251
Step length (cm) 35.3 (6.2) 41.1 (6.2) <0.001
Walking speed (cm/s) 59.9 (13.5) 71.1 (15.8) <0.001
TOC, time of cross over in hip flexion/extension moment; H3, late swing
power burst in hip joint flexion/extension power; HFI, hip flexor index.
Data are presented as mean (SD).
All patients underwent bilateral femoral derotation osteotomy, rectus femoris
transfer, distal hamstring lengthening, and tendo-Achilles lengthening as
single event multilevel surgery.
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lengths was similar in the patients and control group
suggesting that muscle excursion was not significantly
different. The kinetic variable, including the time of
crossover in the hip flexion-extension moment and
the power burst of the hip flexor in late stance, were
similar in the patients and controls. In this study, the
maximum psoas length, hip flexor index and sagittal
pelvic motion showed favorable discriminant validity.
The correlation coefficient between the maximum
psoas length and maximum hip extension in stance
was -0.420 (p= 0.065) in the control group whereas it
was -0.933 in the patients (p < 0.001). The shortened
maximum psoas length in the patients appeared to
limit the maximum extension of the hip joint. How-
ever, the maximum psoas length might not have been
the limiting factor in maximum hip extension in the
control group. This could have cause different corre-
lation coefficients of the two groups between maxi-
mum psoas length and maximum hip extension in
stance.
It has been reported that the psoas length could be
confounded by the femoral anteversion [30], which is
supported by the results of this study. The psoas length
increased post-operatively, even though no psoas proce-
dures had been performed in addition to femoral dero-
tation osteotomy. Therefore, femoral derotation
osteotomy may improve the dynamic psoas length possi-
b l yb ym o v i n gt h el e s s e rt r o c h a n t e rf o r w a r d .H o w e v e r ,
this requires further examination.
This study had some limitations. First, although small
changes in the kinetic and kinematic variables in the
study were statistically significant, they may have been
due to marker placement variability, despite this being
performed by a single experienced operator. Second, the
3D psoas length did not reflect the lumbar spinal
motion which could affect the real psoas length signifi-
cantly because the model did not contain the trunk
marker sets. Therefore, the 3D modeled psoas length
might not be as accurate as expected.
Conclusions
The patients with cerebral palsy showed a shorter psoas
length than the normal control group. The hip flexor
index and psoas length showed good discriminant validity.
There was an excellent correlation between the maximum
psoas length and maximum hip extension in the patients
group. There was evidence that estimated psoas length
could be improved after femoral derotation osteotomy,
even though no psoas procedure had been performed.
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